# Ensysce Biosciences (ENSC) — Overview

ENSC · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ensc

## Price

Last close $0.60 on Oct 15, 2026. 52-week range $0.25 – $2.57.

## Company profile

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $4.5M |
| Revenue (quarter) | $1.2M |
| Revenue growth (year over year) | -15.10% |
| Gross profit (trailing twelve months) | $4.5M |
| Gross margin | 100.00% |
| Net income (trailing twelve months) | −$12.6M |
| Net income (quarter) | −$2.6M |
| Net income growth (year over year) | -48.30% |
| Net margin | -280.49% |
| Return on equity | -968.33% |
| EPS (trailing twelve months) | −$2.56 |
| Book value per share | −$0.05 |
| P/E (trailing twelve months) | — |
| Price to book | — |
| Debt to assets | 137.56% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Ensysce Biosciences (ENSC) profitable?

No. Ensysce Biosciences reported a net loss of $12.6M over the trailing twelve months.

### How much revenue does Ensysce Biosciences (ENSC) make?

Ensysce Biosciences generated $4.5M in revenue over the trailing twelve months, down 15.10% year over year.

### How do I buy stock in Ensysce Biosciences (ENSC)?

ENSC trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).